Oxford BioMedica tanks 24% after earnings alert; brokers take stock
Shares in Oxford BioMedica PLC (LSE:OXB) fell 19% to 479p after the cell and gene therapy manufacturer cut its 2026 guidance, a reaction that reflects the scale of the earnings hit rather than the revenue shortfall alone. Peel Hunt and Stifel, the two brokers to publish on the update, both...
Shares in Oxford BioMedica PLC (LSE:OXB) fell 19% to 479p after the cell and gene therapy manufacturer cut its 2026 guidance, a reaction that reflects the scale of the earnings hit rather than the revenue shortfall alone. Peel Hunt and Stifel, the two brokers to publish on the update, both...
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
